Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0001209191-22-011470

Options or other derivatives

  • PRESIDENT AND CEO acquired 650,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lehrer-Graiwer Joshua PRESIDENT AND CEO 2022-02-16 Grant or award · Stock Option (right to buy) +650,000 650,000 D: show line 1 in the form
Loading xslF345X03/doc4.xml…